Plasmodium vivax Controlled Human Malaria Infection - Progress and Prospects

Ruth O Payne; Paul M Griffin; James S McCarthy; Simon J Draper

doi:10.1016/j.pt.2016.11.001

Plasmodium vivax Controlled Human Malaria Infection - Progress and Prospects

Trends Parasitol. 2017 Feb;33(2):141-150. doi: 10.1016/j.pt.2016.11.001. Epub 2016 Dec 10.

Authors

Ruth O Payne¹, Paul M Griffin², James S McCarthy³, Simon J Draper⁴

Affiliations

¹ The Jenner Institute Laboratories, Old Road Campus Research Building, University of Oxford, Oxford, OX3 7DQ, UK; The Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, OX3 7LE, UK. Electronic address: ruth.payne@ndm.ox.ac.uk.
² QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Queensland 4006, Australia; Q-Pharm Pty Ltd, Brisbane, Australia; Department of Medicine and Infectious Diseases, Mater Hospital and Mater Medical Research Institute, Brisbane, Australia; The University of Queensland, Brisbane, Australia.
³ QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Queensland 4006, Australia; The University of Queensland, Brisbane, Australia.
⁴ The Jenner Institute Laboratories, Old Road Campus Research Building, University of Oxford, Oxford, OX3 7DQ, UK. Electronic address: simon.draper@ndm.ox.ac.uk.

Abstract

Modern controlled human malaria infection (CHMI) clinical trials have almost entirely focussed on Plasmodium falciparum, providing a highly informative means to investigate host-pathogen interactions as well as assess potential new prophylactic and therapeutic interventions. However, in recent years, there has been renewed interest in Plasmodium vivax, with CHMI models developed by groups in Colombia, the USA, and Australia. This review summarizes the published experiences, and examines the advantages and disadvantages of the different models that initiate infection either by mosquito bite or using a blood-stage inoculum. As for P. falciparum, CHMI studies with P. vivax will provide a platform for early proof-of-concept testing of drugs and vaccines, accelerating the development of novel interventions.

Keywords: CHMI; IBSM; malaria; vivax.

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Host-Pathogen Interactions / immunology
Host-Pathogen Interactions / physiology*
Humans
Malaria, Falciparum / prevention & control
Malaria, Vivax / physiopathology
Malaria, Vivax / prevention & control*
Models, Biological
Plasmodium falciparum / physiology
Plasmodium vivax / physiology

Abstract

Publication types

MeSH terms

Grants and funding